Superworth

Pulse Biosciences shares outstanding PLSE

Diluted shares outstanding, averaged over each quarter, from 2015.

Latest quarter, to Sep 30, 2022
37.2M
On a year earlier
+25.5%
more shares

Pulse Biosciences had 37.2M diluted shares outstanding on average in Q3 FY22, the quarter to Sep 30, 2022.

That is 25.5% more than a year earlier, so each share owns a little less of the company.

Shares outstanding over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearShares, fourth quarterChange
FY202129.6M+17%
FY202025.4M+22%
FY201920.8M+18%
FY201817.7M+7%
FY201716.6M+24%
FY201613.3M+76%
FY20157.6Mn/a

Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.

Quarter by quarter

QuarterEndedShares outstandingOn a year earlier
Q3 FY2237.2M+25%
Q2 FY2231.5M+19%
Q1 FY2229.7M+14%
Q4 FY2129.6M+17%
Q3 FY2129.6M+17%
Q2 FY2126.5M+23%
Q1 FY2126.1M+25%
Q4 FY2025.4M+22%
Q3 FY2025.2M+21%
Q2 FY2021.5M+4%
Q1 FY2020.8M+1%
Q4 FY1920.8M+18%

What the shares outstanding tells you

Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.

A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.

More on Pulse Biosciences

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.